Renephra's Unattributed Round

Renephra raised a round of funding on April 14, 2016. Investors include Deepbridge Capital.

Renephra is developing novel technology to tackle treatment resistant fluid overload in heart failure and chronic oedema, grounded in world-class research and clinical excellence.…

Articles about Renephra's Unattributed Round: